Comparative analysis of monkeypox virus infection of cynomolgus Macaques by the intravenous or intrabronchial inoculation route

Journal of Virology

Volumn 85, Issue 5, 2011, Pages 2112-2125

  Johnson, Reed F ^a   Dyall, Julie ^a   Ragland, Dan R ^a   Huzella, Louis ^a   Byrum, Russell ^a   Jett, Catherine ^a   St Claire, Marisa ^a   Smith, Alvin L ^a   Paragas, Jason ^a   Blaney, Joseph E ^a   Jahrling, Peter B ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 4; INTERLEUKIN 5; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTRALIZING ANTIBODY; RANTES; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE MODEL; EXPOSURE; FEVER; GEOGRAPHIC DISTRIBUTION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INOCULATION; INTERSTITIAL PNEUMONIA; MACACA FASCICULARIS; MONKEYPOX; MONKEYPOX VIRUS; NONHUMAN; NOSE SMEAR; POLYMERASE CHAIN REACTION; PRIMATE; PRIORITY JOURNAL; VIREMIA; VIRUS LOAD; VIRUS PATHOGENESIS; VIRUS PNEUMONIA; VIRUS SHEDDING; VIRUS STRAIN;

ANIMALS; ANTIBODIES, VIRAL; BRONCHI; CERCOPITHECUS AETHIOPS; DISEASE MODELS, ANIMAL; HUMANS; INJECTIONS, INTRAVENOUS; MACACA FASCICULARIS; MONKEYPOX; MONKEYPOX VIRUS; VERO CELLS; VIRUS SHEDDING;

MACACA; MONKEYPOX VIRUS; PRIMATES;

EID: 79551700983     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01931-10     Document Type: Article

References (43)

1. Arita, I., and D. A. Henderson. 1968. Smallpox and monkeypox in non-human primates. Bull. World Health Organ. 39:277-283.
2. Arita, I., et al. 1985. Human monkeypox: a newly emerged orthopoxvirus zoonosis in the tropical rain forests of Africa. Am. J. Trop. Med. Hyg. 34:781-789.
3. Breman, J. G., and D. A. Henderson. 2002. Diagnosis and management of smallpox. N. Engl. J. Med. 346:1300-1308.
4. Brody, S. L., et al. 1994. Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA. Hum. Gene Ther. 5:821-836.
5. Chapman, J. L., et al. 2010. Animal models of orthopoxvirus infection. Vet. Pathol. 47:852-870.
6. Chen, N., et al. 2005. Virulence differences between monkeypox virus isolates from West Africa and the Congo basin. Virology 340:46-63. (Pubitemid 41191177)
7. Di Giulio, D. B., and P. B. Eckburg. 2004. Human monkeypox: an emerging zoonosis. Lancet Infect. Dis. 4:15-25.
8. Earl, P. L., et al. 2004. Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox. Nature 428:182-185. (Pubitemid 38374314)
9. Earl, P. L., J. L. Americo, and B. Moss. 2003. Development and use of a vaccinia virus neutralization assay based on flow cytometric detection of green fluorescent protein. J. Virol. 77:10684-10688. (Pubitemid 37129714)
10. Edghill-Smith, Y., et al. 2005. Smallpox vaccine does not protect macaques with AIDS from a lethal monkeypox virus challenge. J. Infect. Dis. 191:372-381.
11. Edghill-Smith, Y., et al. 2005. Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus. Nat. Med. 11:740-747.
12. Fennerty, M. B. 1996. Polio and small pox: diseases of historical interest because of vaccines. Will this also apply to Helicobacter pylori? Am. J. Gastroenterol. 91:170-171.
13. Foege, W. H., J. D. Millar, and J. M. Lane. 1971. Selective epidemiologic control in smallpox eradication. Am. J. Epidemiol. 94:311-315.
14. Hammarlund, E., et al. 2008. Monkeypox virus evades antiviral CD4+ and CD8+ T cell responses by suppressing cognate T cell activation. Proc. Natl. Acad. Sci. U. S. A. 105:14567-14572.
15. Henderson, D. A., et al. 1999. Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 281:2127-2137. (Pubitemid 29264692)
16. Hooper, J. W., et al. 2004. Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox. J. Virol. 78:4433-4443. (Pubitemid 38501063)
17. Huggins, J., et al. 2009. Nonhuman primates are protected from smallpox virus or monkeypox virus challenges by the antiviral drug ST-246. Antimicrob. Agents Chemother. 53:2620-2625.
18. Huhn, G. D., et al. 2005. Clinical characteristics of human monkeypox, and risk factors for severe disease. Clin. Infect. Dis. 41:1742-1751.
19. Hutson, C. L., et al. 2010. Dosage comparison of Congo Basin and West African strains of monkeypox virus using a prairie dog animal model of systemic orthopoxvirus disease. Virology 402:72-82.
20. Jahrling, P. B., E. A. Fritz, and L. E. Hensley. 2005. Countermeasures to the bioterrorist threat of smallpox. Curr. Mol. Med. 5:817-826.
21. Jahrling, P. B., et al. 2004. Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox. Proc. Natl. Acad. Sci. U. S. A. 101:15196-15200.
22. Jezek, Z., et al. 1987. Human monkeypox: clinical features of 282 patients. J. Infect. Dis. 156:293-298.
23. Larsen, M. H., et al. 2009. Efficacy and safety of live attenuated persistent and rapidly cleared Mycobacterium tuberculosis vaccine candidates in nonhuman primates. Vaccine 27:4709-4717.
24. Learned, L. A., et al. 2005. Extended interhuman transmission of monkeypox in a hospital community in the Republic of the Congo, 2003. Am. J. Trop. Med. Hyg. 73:428-434.
25. Likos, A. M., et al. 2005. A tale of two clades: monkeypox viruses. J. Gen. Virol. 86:2661-2672.
26. Martin, D. B. 2002. The cause of death in smallpox: an examination of the pathology record. Mil. Med. 167:546-551.
27. Messaoudi, I., et al. 2009. Simian varicella virus infection of rhesus macaques recapitulates essential features of varicella zoster virus infection in humans. PLoS Pathog. 5:e1000657.
28. Parker, S., et al. 2007. Human monkeypox: an emerging zoonotic disease. Future Microbiol. 2:17-34. (Pubitemid 46766996)
29. Reed, K. D., et al. 2004. The detection of monkeypox in humans in the Western Hemisphere. N. Engl. J. Med. 350:342-350.
30. Reynolds, M. G., et al. 2006. Clinical manifestations of human monkeypox influenced by route of infection. J. Infect. Dis. 194:773-780.
31. Ricketts, T. F. 1910. The diagnosis of smallpox. Funk and Wagnalls, New York, NY.
32. Rimoin, A. W., et al. 2010. Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo. Proc. Natl. Acad. Sci. U. S. A. 107:16262-16267.
33. Rubins, K. H., et al. 2008. Comparative analysis of viral gene expression programs during poxvirus infection: a transcriptional map of the vaccinia and monkeypox genomes. PLoS One 3:e2628.
34. Saijo, M., et al. 2009. Virulence and pathophysiology of the Congo Basin and West African strains of monkeypox virus in non-human primates. J. Gen. Virol. 90:2266-2271.
35. Sbrana, E., et al. 2007. Comparative pathology of North American and central African strains of monkeypox virus in a ground squirrel model of the disease. Am. J. Trop. Med. Hyg. 76:155-164.
36. Sbrana, E., et al. 2007. Efficacy of the antipoxvirus compound ST-246 for treatment of severe orthopoxvirus infection. Am. J. Trop. Med. Hyg. 76:768-773.
37. Sofi Ibrahim, M., et al. 2003. Real-time PCR assay to detect smallpox virus. J. Clin. Microbiol. 41:3835-3839.
38. Stittelaar, K. J., et al. 2001. Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques. Vaccine 19:3700-3709. (Pubitemid 32522768)
39. Stittelaar, K. J., et al. 2005. Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus. J. Virol. 79:7845-7851. (Pubitemid 40756819)
40. Stittelaar, K. J., et al. 2006. Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection. Nature 439:745-748. (Pubitemid 43237623)
41. Tesh, R. B., et al. 2004. Experimental infection of ground squirrels (Spermophilus tridecemlineatus) with monkeypox virus. Emerg. Infect. Dis. 10:1563-1567.
42. WHO. 2009. Selected priority diseases under weekly surveillance: cases and deaths in 2009. Afr. Health Monit. 11:56-57.
43. Zaucha, G. M., et al. 2001. The pathology of experimental aerosolized monkeypox virus infection in cynomolgus monkeys (Macaca fascicularis). Lab. Investig. 81:1581-1600. (Pubitemid 33144422)